Generalizability of EXCEL and NOBLE results to a large registry population with unprotected left main coronary artery disease
Conclusion: In the comparison of a large-sized, all-comer registry, the EXCEL trial might represent better generalizability with respect to baseline characteristics and observed clinical outcomes compared with the NOBLE trial.
Source: Coronary Artery Disease - Category: Cardiology Tags: Original Research Source Type: research
More News: Angioplasty | Coronary Angioplasty | Coronary Artery Bypass Graft | Diabetes | Endocrinology | Heart Attack | Percutaneous Coronary Intervention | Stroke | Study